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Response to letter to the
editor regarding
“Occupational health risks
associated with the use of
germicides in health care”
To the Editor:
We thank the authors of the letter for their comments on the
benefits and risks of using low-level disinfectants on environmen-
tal surfaces in hospitals based on our recent article “Occupational
health risks associated with the use of germicides in health care.”1
We take exception to many of the issues and criticisms raised by
these authors. First, the authors have failed to note the substantial
morbidity and mortality associated with health care–associated in-
fections (HAIs) in the United States. A multistate prevalence survey
estimated that in 2011 there were 648,000 patients with 721,800
HAIs in the United States; approximately 4.0% of inpatients had at
least 1 HAI.2 Additionally, approximately 75,000 patients with HAIs
died during their hospitalization. Second, the authors have failed
to describe the robust scientific literature that demonstrates the
role of the contaminated surface environment as a risk factor for
the transmission of HAIs.3,4 Although the authors note the impor-
tance of terminal room cleaning on preventing subsequent patients
admitted to the room from acquiring a multidrug-resistant organ-
ism (MDRO), they do not cite the data that daily disinfection reduces
the acquisition of MDROs on the hands of health care providers
after contact with high-touch room surfaces,5 or that use of daily
disinfection has been shown to decrease the incidence of MDRO-
associated HAIs.6 Further, they did not note the importance of
disinfecting shared medical devices, such as glucometers.7 Third,
the authors misstated that “terminal room ‘cleaning’ subsequent
to occupancy by a patient with VRE [vancomycin-resistant entero-
cocci], MRSA [methicillin-resistant Staphylococcus aureus], S aureus
or C difficile [Clostridium difficile] can prevent illness in the next
occupant.” In fact, the study they cited recommended environmen-
tal room decontamination not cleaning.8 Further, although improved
cleaning has been shown to decrease contamination of surfaces
with C difficile, the addition of enhanced standard disinfection of
C difficile rooms, which includes daily disinfection, further reduced
environmental contamination.9 It is not surprising that use of a
disinfectant is superior to a cleaning agent alone for reducing en-
vironmental contamination and HAI because cleaning agents, unlike
disinfectants, do not inactivate microbes, therefore allowing trans-
fer of microbes between surfaces.10 Fourth, the authors correctly
noted that many hospital infections are associated with medical
devices, surgical site infections, inadequate hand hygiene compli-
ance, and antibiotics. However, there is growing evidence that non–
device-related infections are increasingly important HAIs.11 Further,
the Centers for Disease Control and Prevention (CDC) and multi-
ple professional organizations have called for not just a reduction
in HAIs but an elimination of HAIs.12 This cannot be achievedwithout
implementation of interventions to eliminate all transmissionmecha-
nisms of health care–associated pathogens, which would include
disinfection of the surface environment in hospital rooms. Fifth,
the authors correctly note that antimicrobial use is a precipitant
for the development of MDROs. They imply but do not state that
disinfectant use may lead to an increase in MDROs. However, there
is a robust literature that currently used surface disinfectants do
not in fact lead to an increase in MDROs.13 Sixth, the authors make
a number of misleading statements regarding our recommenda-
tions including that we provided “blanket advice to disinfect
environmental surfaces” and we “encouraged indiscriminate use
of disinfectants on environmental surfaces.” If fact, we recom-
mended the use of disinfectants only for decontamination of
environmental surfaces in contact with patients (ie, patient rooms,
procedure rooms, operating rooms) and did not recommend their
use in nonpatient areas (eg, offices). Seventh, the authors failed to
note that our recommendations are consistent with evidence-
based guidelines, including those published by the CDC.14 Eighth,
the authors failed to state that at UNC Hospitals we use disinfec-
tants and provide personal protective equipment (PPE) to our health
care personnel per the U.S. Environmental Protection Agency–
approved label and in accordance with the manufacturer’s
instructions. Ninth, at UNC Hospitals we take a broader view of
protecting our health care providers than discussed by these authors.
Therefore, we teach all health care personnel the proper use of
disinfectants and provide appropriate PPE to all health care per-
sonnel, not just workers, because trainees and volunteers are not
workers. Tenth, much of the literature is focused on risks of asthma
and dermatitis from high-level disinfectants; many fewer studies
have focused on currently used low-level disinfectant products. Elev-
enth, the authors state that “encouraging indiscriminate use of
disinfectants on environmental surfaces may also lead to under-
treatment of surfaces which do pose a real risk of microbe transfer
and subsequent disease.” As previously noted, we take issue with
the use of the word indiscriminate because we adhere to the CDC’s
guidelines on disinfection and sterilization, but one should also
note that there is no evidence that by adhering to the CDC’s guide-
lines (eg, regular disinfection of patient room surfaces [eg, once
daily], disinfection of shared medical devices), we are undertreat-
ing surfaces the authors state are proven to decrease HAIs, such as
terminal room disinfection. Finally, the current standard for evidence-
based guidelines is the use of the Grading of Recommendations
Assessment, Development and Evaluation, which is used by the
CDC15 and professional organizations, such as the Infectious Dis-
eases Society of America.16 The Grading of Recommendations
Assessment, Development and Evaluation only recognizes meth-
odologically well-conducted randomized clinical trials and
prospective cohort studies. The authors state that >40 articles “have
documented the association of cleaning products, and specifically
disinfectants used in hospitals, with asthma.” However, none of
the primary literature cited by the authors demonstrates this as-
sociation using a randomized clinical trial or prospective cohort
study.17-19
We do agree with the authors that additional and improved re-
search should be undertaken, especially carefully done prospective
studies with appropriate clinical tests to document possible aller-
gies to low-level disinfectants and disinfectant-precipitated asthma
(eg, pulmonary function tests, human challenge studies). We also
agree that health care facilities should provide health care person-
nel with the proper training and PPE to minimize exposure to
chemicals used in the health care environment, including both high-
and low-level disinfectants. Manufacturers should be encouraged
to develop new low-level disinfectants that are effective while having
a potentially lower toxicity, such as improved hydrogen peroxide
products.20 Finally, it is important to recognize that scientific evi-
dence has demonstrated that low-level disinfectants used on
environmental surfaces in patient rooms and sharedmedical devices
in hospitals play a key role in reducing the incidence of HAIs, which
are a major source of morbidity and mortality in the United States.
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